BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2011
View Archived Issues
Finasteride reduces priapism in young males with sickle cell disease
Read More
Updated preclinical and clinical data presented on antiviral CMX-001
Read More
Scientists at Eiger BioPharmaceuticals prepare new azaindazoles for HCV infections
Read More
Novel protein kinase inhibitors disclosed
Read More
Neuropeptide Y2 receptor agonists described by Roche as useful for metabolic disorders
Read More
JNJ-37822681 shows efficacy and promising metabolic profile in phase II trial in schizophrenia
Read More
Nizatidine improves symptoms of functional dyspepsia
Read More
Tofacitinib is efficacious in phase II trial in ulcerative colitis
Read More
RBM acquires biomarker research from Satoris for neurodegenerative disease testing
Read More
Tekmira and BMS expand research agreement to evaluate lipid nanoparticle formulations
Read More
Biomay's BM-32 vaccine enters phase I/II skin test trial in grass pollen allergy
Read More
New activators of soluble guanylate cyclase described
Read More
Enanta Pharmaceuticals discloses novel HCV protease inhibitors
Read More
University of Michigan presents new Smac mimetics with IAP-inhibiting activity
Read More
Takeda Pharmaceutical to acquire Nycomed
Read More
FDA approves Abbott's RealTime PCR molecular test for hepatitis C
Read More
NORD grants 2011 Corporate Award to Recordati for Carbaglu
Read More
Allon presents updated phase II/III data on davunetide in progressive supranuclear palsy
Read More
SuppreMol to in-license antibody against IL-3 for rheumatoid arthritis
Read More
Evotec and Roche terminate proof-of-concept trial of EVT-101 in depression
Read More
Synergy Pharmaceuticals advances GC-C agonist program for lowering cholesterol
Read More
WIBP and ProMetic Life Sciences expand strategic partnership agreement
Read More
Biothera initiates dosing in phase III trial of Imprime PGG with Erbitux
Read More
TxCell cleared to extend phase I/II trial of Ovasave in Crohn's disease
Read More
Enrollment begins in phase II TG-C trial in degenerative joint disease of the knee
Read More